Status:
RECRUITING
Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"
Lead Sponsor:
University Hospital, Toulouse
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Takeda
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Brief Summary
Actually very few real life data are available for patients with multiple myeloma (MM), whereas they're playing a more and more important role in health care decisions. Treatments choice for medical c...
Detailed Description
Primary objective : Describe health care pathways of patients with MM living in West Occitanie according to socio-demographic patients' caracteristics, their comorbidities and their initial disease s...
Eligibility Criteria
Inclusion
- Patient living in the West-Occitanie region
- Patient with a diagnosis of symptomatic multiple myeloma (Rajkumar et al, Lancet Oncology 2014)
Exclusion
- Patient opposed to this research
- Patient under legal protection
Key Trial Info
Start Date :
December 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2031
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04888039
Start Date
December 15 2021
End Date
June 1 2031
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IUCT-Oncopole - Toulouse University Hospital
Toulouse, West-Occitanie, France, 31059